Table 3 Rates of eating disorder symptoms, suicidality, treatment-seeking intentions, and current treatment status by probable eating disorder diagnostic/risk category
| Â | ARFID | AN | BN | BED | PD | UFED | At risk | Low/No risk | Significance | Pairwise Comparisons |
|---|---|---|---|---|---|---|---|---|---|---|
Weight/shape concernsa, M (SD) | 24.1 (12.5) | 78.2 (15.1) | 78.3 (13.4) | 72.2 (15.2) | 81.5 (17.3) | 61.8 (21.2) | 65.0 (16.1) | 28.2 (13.6) | p < 0.001, η2 =0 .44 | AN, BN, BED, PD, UFED, at risk, low/no risk > ARFID |
Binge eating, M (SD) | 0.2 (0.6) | 6.54 (18.3) | 24.0 (30.4) | 30.3 (33.1) | 0.0 (0.0) | 9.6 (21.5) | 0.5 (0.8) | 0.5 (1.6) | p < 0.001, η2 = 0.16 | AN, BN, BED, UFED > ARFID |
Vomiting, M (SD) | 0.0 (0.2) | 9.7 (38.7) | 8.0 (24.4) | 0.1 (0.3) | 32.1 (94.2) | 1.1 (6.7) | 0.0 (0.2) | 0.1 (1.2) | p < 0.001, η2 = 0.07 | AN, BN, PD > ARFID |
Laxative/diuretic use, M (SD) | 0.0 (0.2) | 6.7 (19.5) | 5.0 (18.4) | 0.0 (0.2) | 25.0 (40.1) | 0.8 (5.6) | 0.1 (0.3) | 0.0 (0.2) | p < 0.01, η2 = 0.10 | AN, BN, PD > ARFID |
Fasting, M (SD) | 0.1 (0.3) | 14.6 (25.3) | 10.0 (17.9) | 0.1 (0.4) | 17.5 (27.0) | 6.1 (15.7) | 0.2 (0.5) | 0.1 (0.8) | p < 0.001, η2 = 0.09 | AN, BN, PD, UFED > ARFID |
Excessive exercise, M (SD) | 0.1 (0.3) | 15.2 (28.0) | 9.7 (19.5) | 0.1 (0.3) | 17.1 (28.9) | 5.8 (16.8) | 0.1 (0.4) | 0.1 (0.8) | p < .001, η2 = .08 | AN, BN, PD, UFED > ARFID |
BMI, M (SD) | 21.4 (5.4) | 17.1 (1.3) | 29.1 (8.6) | 35.1 (9.7) | 24.9 (6.3) | 28.1 (8.9) | 27.1 (8.7) | 25.5 (6.6) | p < 0.001, η2 = 0.16 | BN, BED, UFED > ARFID > AN |
Dietary restrictionb, n (%) | 610 (25.7%) | 2273 (100%) | 7859 (52.7%) | 1197 (16.4%) | 736 (84.8%) | 6867 (45.3%) | 1983 (41.3%) | 175 (7.4%) | p < 0.001, V = 0.40 | AN, BN, PD, UFED, at risk > ARFID > BED, low/no risk |
Suicidal ideation, n (%) | 830 (34.9%) | 1285 (56.5%) | 6814 (45.7%) | 2275 (31.2%) | 476 (54.8%) | 5357 (35.3%) | 1366 (28.5%) | 200 (8.4%) | p < 0.001, V = 0.20 | AN, BN, PD > ARFID > BED, at risk, low/no risk |
Treatment-seeking intentions, n (%) | 25 (47.2%) | 16 (34.0%) | 152 (55.1%) | 70 (66.7%) | 6 (46.2%) | 128 (46.4%) | 35 (35.0%) | – | p < 0.05, V = 0.19 | BN, BED > ARFID > AN, PD, UFED, at risk |
Currently in treatment, n (%) | 57 (2.4%) | 134 (5.9%) | 415 (2.8%) | 157 (2.2%) | 61 (7.0%) | 409 (2.7%) | 114 (2.4%) | – | p < 0.01, V = 0.06 | AN, PD > ARFID |